Data is not available at this time.
INTAGE HOLDINGS Inc. is a Japan-based marketing research firm specializing in data-driven insights for consumer goods, healthcare, and business intelligence sectors. The company operates through three core segments: Marketing Support for consumer goods and services, Marketing Support for healthcare, and Business Intelligence. Its services include panel and custom research, prescription data analysis, and IT infrastructure solutions, catering to clients such as manufacturers, advertisers, pharmaceutical firms, and government agencies. INTAGE differentiates itself through deep industry expertise, proprietary data modeling, and a diversified service portfolio that spans market research, IT outsourcing, and enterprise solutions. The firm holds a strong position in Japan’s competitive marketing research landscape, leveraging its long-standing reputation and technological capabilities to serve high-demand industries like healthcare and consumer goods. Its international presence further bolsters its market reach, though domestic operations remain its primary revenue driver.
In FY 2023, INTAGE reported revenue of ¥61.4 billion, with net income of ¥3.5 billion, reflecting a net margin of approximately 5.7%. Operating cash flow stood at ¥2.7 billion, while capital expenditures totaled ¥1.1 billion, indicating disciplined spending. The diluted EPS of ¥91.21 underscores steady earnings generation, supported by efficient cost management and a diversified client base.
The company’s earnings power is evident in its consistent profitability, with a focus on high-margin services like healthcare research and IT solutions. Capital efficiency is demonstrated by its moderate debt level (¥935 million) against cash reserves of ¥12.6 billion, suggesting a conservative balance sheet structure. The firm’s ability to generate positive operating cash flow further highlights its operational resilience.
INTAGE maintains a robust financial position, with cash and equivalents of ¥12.6 billion outweighing total debt of ¥935 million. This low leverage ratio provides flexibility for strategic investments or acquisitions. The balance sheet reflects prudent liquidity management, with no significant near-term refinancing risks, supporting long-term stability.
Revenue growth has been steady, driven by demand for data analytics in healthcare and consumer sectors. The company’s dividend payout of ¥65.5 per share signals a commitment to shareholder returns, though its yield remains modest relative to earnings. Future growth may hinge on expanding high-value services and international markets.
With a market cap of ¥66.2 billion and a beta of 0.48, INTAGE is perceived as a lower-volatility stock in the advertising and research sector. The valuation reflects expectations of stable, albeit not explosive, growth, aligned with its niche expertise and mature market position.
INTAGE’s strengths lie in its specialized research capabilities, entrenched client relationships, and diversified service offerings. The growing reliance on data-driven decision-making in healthcare and consumer markets positions the company favorably. Challenges include competition from global players and the need to innovate in AI-driven analytics. The outlook remains cautiously optimistic, with potential upside from strategic tech investments.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |